abstract |
The present invention relates to compounds capable of inhibiting, modulating and / or controlling signaling of both receptor and non-receptor tyrosine kinases. The compounds of the present invention have a core structure that includes a substituted pyrrole moiety. The invention also relates to pharmaceutically acceptable salts, hydrates and stereoisomers of these compounds. |